Industries > Pharma > Tissue Diagnostics Market Report 2019-2029

Tissue Diagnostics Market Report 2019-2029

Forecasts by Product (Consumables, Instruments), by Product (Immunohistochemistry, in Situ Hybridization, Digital Pathology, Others), by Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, Others), by End User (Hospitals, Research Labs, Pharmaceutical Companies, Research Organizations) Plus Analysis of Leading Companies

PAGES: 125
PRODUCT CODE: PHA0640
SUBMARKET:

DOWNLOAD FREE SAMPLE
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0640 Category: Tag:

Visiongain’s new report the Tissue Diagnostics Market Report 2019-2029: Forecasts by Product (Consumables, Instruments), by Product (Immunohistochemistry, in Situ Hybridization, Digital Pathology, Others), by Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, Others), by End User (Hospitals, Research Labs, Pharmaceutical Companies, Research Organizations), plus analysis of leading companies operating in the global tissue diagnostics market.

List of companies identified in global tissue diagnostics market report are Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Product, Siemens Healthineers, bioMérieux SA, Johnson & Johnson Services, Inc., GE Healthcare, and DiaGenic.

Tissue Diagnostics Market Report 2019-2029, By Product

– Consumables
– Antibodies
– Kits
– Reagents
– Probes

– Instruments
– Slide-Staining Systems
– Scanners
– Tissue-Processing Systems
– Others

Tissue Diagnostics Market Report 2019-2029, By Technology
– Immunohistochemistry
– in Situ Hybridization
– Digital Pathology
– Others

Tissue Diagnostics Market Report 2019-2029, By Diseases
– Breast Cancer
– Gastric Cancer
– Lymphoma
– Prostate Cancer
– Non-Small Cell Lung Cancer
– Others

Tissue Diagnostics Market Analysis , By End User
– Hospitals
– Research Labs
– Pharmaceutical Companies
– Research Organisations

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Tissue Diagnostics Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Tissue Diagnostics Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022

READ

Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022

READ

Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022

READ